<DOC>
	<DOC>NCT02827227</DOC>
	<brief_summary>The objective was to identify factors associated with the normalization of the CD4/CD8 ratio (&gt;=1) in patients with a history of primary HIV infection (PHI) and long-term combined antiretroviral therapy (cART).</brief_summary>
	<brief_title>Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)</brief_title>
	<detailed_description />
	<criteria>all HIV patients with a known history of PHI and a minimum of 2 years of effective cART (&lt; 200 copies/mL) without interruption or virological failure Patients with hepatitis C or B virus coinfection or with a history of neoplasia or immunosuppressive therapy after the date of PIH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV-infected patients</keyword>
	<keyword>cART</keyword>
	<keyword>immune restoration</keyword>
	<keyword>markers</keyword>
</DOC>